Preoperative breast magnetic resonance imaging in early breast cancer

Cancer

Volumn 115, Issue 8, 2009, Pages 1621-1630

  Tendulkar, Rahul D ^a   Chellman Jeffers, Melanie ^a   Rybicki, Lisa A ^a   Rim, Alice ^a   Kotwal, Ashwin ^a   Macklis, Roger ^a   Obi, Betty B ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Breast cancer; Magnetic resonance imaging; Partial breast irradiation

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER STAGING; CANCER SURGERY; CARCINOMA IN SITU; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EARLY CANCER; FEMALE; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; MEDICAL RECORD REVIEW; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT CANCER; PARTIAL MASTECTOMY; PATIENT SELECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TUMOR BIOPSY;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PREOPERATIVE CARE; RETROSPECTIVE STUDIES;

EID: 65249100209     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24172     Document Type: Article

References (32)

1. Saslow D, Boetes C, Burke W, et al. American cancer society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75-89.
2. Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007;356:1295-1303.
3. Kuhl CK. Current status of breast MR imaging. Part 2. Clinical applications. Radiology. 2007;244:672-691.
4. Kuhl CK, Schrading S, Bieling HB, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet. 2007;370:485-492.
5. Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233:830-849.
6. Harms SE, Flamig DP, Hesley KL, et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology. 1993;187:493-501.
7. Sardanelli F, Giuseppetti GM, Panizza P, et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol. 2004;183:1149-1157.
8. Drew PJ, Chatterjee S, Turnbull LW, et al. Dynamic contrast enhanced magnetic resonance imaging of the breast is superior to triple assessment for the pre-operative detection of multifocal breast cancer. Ann Surg Oncol. 1999;6:599-603.
9. Dao TN, Lamont JP, Knox SM. Clinical utility of breast magnetic resonance imaging in patients presenting with primary breast cancer. Proc (Bayl Univ Med Cent). 2007;20:227-230.
10. Deurloo EE, Peterse JL, Rutgers EJ, Besnard AP, Muller SH, Gilhuijs KG. Additional breast lesions in patients eligible for breast-conserving therapy by MRI: impact on preoperative management and potential benefit of computerised analysis. Eur J Cancer. 2005;41:1393-1401.
11. Lee SG, Orel SG, Woo IJ, et al. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology. 2003;226:773-778.
12. Liberman L, Morris EA, Dershaw DD, Abramson AF, Tan LK. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol. 2003;180:901-910.
13. Liberman L, Morris EA, Kim CM, et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol. 2003;180:333-341.
14. Schnall MD, Blume J, Bluemke DA, et al. MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. J Surg Oncol. 2005;92: 32-38.
15. Bilimoria KY, Cambic A, Hansen NM, Bethke KP. Evaluating the impact of preoperative breast magnetic resonance imaging on the surgical management of newly diagnosed breast cancers. Arch Surg. 2007;142:441-445; discussion 445-447.
16. Bedrosian I, Mick R, Orel SG, et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer. 2003;98:468-473.
17. Lee JM, Orel SG, Czerniecki BJ, Solin LJ, Schnall MD. MRI before reexcision surgery in patients with breast cancer. AJR Am J Roentgenol. 2004;182:473-480.
18. Orel SG, Schnall MD, Powell CM, et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology. 1995;196:115-122.
19. Tan JE, Orel SG, Schnall MD, Schultz DJ, Solin LJ. Role of magnetic resonance imaging and magnetic resonance imaging-guided surgery in the evaluation of patients with early-stage breast cancer for breast conservation treatment. Am J Clin Oncol. 1999;22:414-418.
20. Tillman GF, Orel SG, Schnall MD, Schultz DJ, Tan JE, Solin LJ. Effect of breast magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma. J Clin Oncol. 2002;20: 3413-3423.
21. Schelfout K, Van Goethem M, Kersschot E, et al. Contrast-enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol. 2004;30:501-507.
22. Morimoto T, Okazaki K, Komaki K, et al. Cancerous residue in breast-conserving surgery. J Surg Oncol. 1993;52:71-76.
23. Vicini FA, Kestin LL, Goldstein NS. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis. Int J Radiat Oncol Biol Phys. 2004;60:722-730.
24. Kurtz JM, Jacquemier J, Amalric R, et al. Breast-conserving therapy for macroscopically multiple cancers. Ann Surg. 1990;212:38-44.
25. Wilson LD, Beinfield M, McKhann CF, Haffty BG. Conservative surgery and radiation in the treatment of synchronous ipsilateral breast cancers. Cancer. 1993;72:137-142.
26. Kepple J, Layeeque R, Klimberg VS, et al. Correlation of magnetic resonance imaging and pathologic size of infiltrating lobular carcinoma of the breast. Am J Surg. 2005;190:623-627.
27. Quan ML, Sclafani L, Heerdt AS, Fey JV, Morris EA, Borgen PI. Magnetic resonance imaging detects unsuspected disease in patients with invasive lobular cancer. Ann Surg Oncol. 2003;10:1048-1053.
28. Holland R, Connolly JL, Gelman R, et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol. 1990;8:113-118.
29. Boyages J, Recht A, Connolly JL, et al. Early breast cancer: predictors ofbreast recurrence for patients treated with conservative surgery and radiation therapy. Radiother Oncol. 1990;19:29-41.
30. Al-Hallaq H, Mell L, Advani S, Hellman S, Newstead G, Chmura S. Magnetic resonance imaging (MRI) identifies multifocal and multicentric disease in breast cancer patients eligible for the NSABP B-39/RTOG 0413 partial breast irradiation (PBI) trial [abstract]. Int J Radiat Oncol Biol Phys. 2006;66:S179-S180.
31. Horst KC, Ikeda DM, Birdwell RL, et al. Breast magnetic resonance imaging alters patient selection for accelerated, partial breast irradiation [abstract]. Int J Radiat Oncol Biol Phys. 2005;63:S4-S5.
32. Vallow LA, Packianathan S, Deperi ER, McDonough MD, Earle JD, Perez EA. Pre-operative breast magnetic resonance imaging (MRI) influences patient selection for partial breast irradiation [abstract]. J Clin Oncol. 2006; 24:604.